CD24 and breast cancer: CD44+/CD24- breast CSCs are crucial for the prognosis of breast cancer (Kaverina et al., 2017; Mylona et al., 2008), but the potential prognostic values of CD44-/CD24- breast cancer cells are rarely studied.